Lei Yang

Lei Yang

Auto-generated profile, based on publicly available information

Lei Yang

Nanjing Maternal and Child Health Hospital of Nanjing Medical University, Nanjing 210004, China; Institute of Pediatrics, Nanjing Medical University, Nanjing 210029, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2014 in Molecular and Cellular Endocrinology
Verified
Journal Article
Open access
LCLing Chen
Ling Chen
YDYong-Mei Dai
Yong-Mei Dai
CJChen-Bo Ji
Chen-Bo Ji
LYLei Yang
Lei Yang
CSChun-Mei Shi
Chun-Mei Shi
XGXirong Guo
Xirong Guo
Visceral obesity is an independent risk factor for metabolic syndrome, and abnormal fat accumulation is linked to increases in the number and size of adipocytes. MiR-146b was a miRNA highly expressed in mature adipocytes while very lowly expressed in human mesenchymal stem cells (hMSCs) and human visceral preadipocytes (vHPA). In this paper, we mainly focused on the roles of miR-146b in adipogenesis. We found miR-146b could inhibit the proliferation of visceral preadipocytes and promote their differentiation. MiR-146b in human visceral adipocytes inhibited the expression of KLF7, a member of the Kruppel-like transcription factors, as demonstrated by a firefly luciferase reporter assay, indicating that KLF7 is a direct target of the endogenous miR-146b. MiR-146b expression was significantly altered in visceral and subcutaneous adipose tissues in human overweight and obese subjects, and in the epididymal fat tissues and brown fat tissues of diet-induced obese mice. Our data indicates that miR-146b may be a new therapeutic target against human visceral obesity and metabolic dysfunction.